Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

G. R. Burmester, P. Mease, B. A.C. Dijkmans, K. Gordon, D. Lovell, R. Panaccione, J. Perez, A. L. Pangan

Research output: Contribution to journalArticlepeer-review

166 Scopus citations

Fingerprint Dive into the research topics of 'Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds